We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Chn5.5
Chondroitin Research
Probably helps
169 peer-reviewed studies
What the evidence says
Probably helps
Chondroitin helped in about half (8/13) of the studies that measured an effect — promising, but not unanimous.
Most evidence is from high-quality meta-analyses and randomised trials published 1971–2026 with a typical study size of 191 participants.
Based on 169 studies · 39 meta-analyses · 112 RCTs · 75,310 total participants
Confidence
High confidence
What the studies found
8helped2unclear3didn't help· 156 more without graded effect data
By outcome
Joint pain & arthritisImproved joint comfort and cartilage support within 8-12 weeks · 8-12 weeks
Probably helps93 studies
Therapeutic & clinical
Mostly mechanism / observational21 studies
Heart & blood pressure
Mostly mechanism / observational6 studies
Safety profile
Mostly mechanism / observational4 studies
InflammationModest reduction in joint pain and stiffness · 8-12 weeks
Too few graded studies1 study
By the numbers
Pulled from 31 studies with measurable effects
Likely real effects
57%
across studies
People studied
75k
typical study: 191 people
Strongest designs
151
39 pooled, 112 randomised
Showed benefit
62%
8/13 studies
How long studies ran
1–4 weeks
1
1–3 months
3
3+ months
5
Populations Studied
Patients with knee osteoarthritis6
Patients with osteoarthritis4
Knee OA patients4
Patients with hand osteoarthritis1
Steady research
34 studies in the last 5 years · Latest meta-analysis: 2025
197119982026
1Safety of anti-osteoarthritis medicationsSystematic ReviewCited 6×n=22,938 · very large study2025
This SR confirms previous evidence on the safety of anti-OA medications from meta-analyses of phase 3 RCTs.
Honvo G et al. · Drugs (2025)
This SR confirms previous evidence on the safety of anti-OA medications from meta-analyses of phase 3 RCTs.
Beyond the evidence here reported, the limitations of this research highlight the urgent need of a reporting guideline for post-marketing safety surveillance studies.
Importantly, real-life safety surveillance of anti-OA medications should be strengthened with large cohort studies with control groups, and results should be disaggregated by disease populations for drugs common to several conditions.
3Pain reduction in hand osteoarthritisMeta-Analysisn=3,965 · very large study2024
In summary, GCSB-5 and CRx-102 exhibit efficacy in alleviating pain and stiffness in HOA, respectively.
Wu R et al. · PloS one (2024)
No clear effect
← WorseNo effectBetter →
GCSB-5, a specific herbal complex that mainly regulate pain in hand osteoarthritis, showed the greatest reduction in pain [WMD = -13.00, 95% CI (-26.69, 0.69)].
CRx-102, s specific medication characterized by its significant effect for relieving joint stiffness symptoms, remarkably mitigated stiffness [WMD = -7.50, 95% CI (-8.90, -6.10)].
Chondroitin sulfate displayed the highest incidence of adverse events [RR = 0.26, 95% CI (0.06, 1.22)].
Our study confirmed that the combination of glucosamine and chondroitin is effective and superior to other treatments in knee osteoarthritis to a certain extent.
Meng Z et al. · Archives of orthopaedic and trauma surgery (2023)
Our study confirmed that the combination of glucosamine and chondroitin is effective and superior to other treatments in knee osteoarthritis to a certain extent.
It is worthwhile to popularize and apply the combination in KOA treatment considering the point of effect, tolerability and economic costs.
Additionally, regarding the limited number of studies and uneven trial quality, more high-quality trials are required to investigate the accurate clinical advantages of the combination.
5Efficacy for osteoarthritis and joint painSystematic ReviewCited 1×n=146 · medium study2025
Overall, the evidence suggests that glucosamine and chondroitin are generally effective and well-tolerated, particularly for managing osteoarthritis and joint pain.
Baden KER et al. · Nutrients (2025)
Huge benefit
← WorseNo effectBetter →
Of the 2013 articles screened, 146 studies were included in our review, with nearly 60% being randomized controlled trials and most conducted in Europe, Asia, or the U.S.
Most studies focused on osteoarthritis and joint pain, with over 90% of efficacy studies reporting positive outcomes and most safety studies indicating minimal or no adverse effects.
Overall, the evidence suggests that glucosamine and chondroitin are generally effective and well-tolerated, particularly for managing osteoarthritis and joint pain.
6Meta-AnalysisCited 38×n=16,427 · very large study2015
The present study provided evidence for the symptomatic efficacy of glucosamine plus chondroitin in the treatment of knee OA.
Zeng C et al. · Scientific reports (2015)
All treatment options showed clinically significant improvement from baseline pain, but only glucosamine plus chondroitin showed clinically significant improvement from baseline function.
In terms of the structure-modifying effect, both glucosamine alone and chondroitin alone achieved a statistically significant reduction in joint space narrowing.
The present study provided evidence for the symptomatic efficacy of glucosamine plus chondroitin in the treatment of knee OA.